Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

✍ Scribed by Buda, A; Floriani, I; Rossi, R; Colombo, N; Torri, V; Conte, P F; Fossati, R; Ravaioli, A; Mangioni, C

• Book ID: 109998044
• Publisher: Nature Publishing Group
• Year: 2004
• Tongue: English
• Weight: 116 KB
• Volume: 90
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6601787